Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""GOWRISHANKAR, Raajaram"" wg kryterium: Autor


Wyświetlanie 1-17 z 17
Tytuł :
Serotonin transporter inhibition and 5-HT2C receptor activation drive loss of cocaine-induced locomotor activation in DAT Val559 mice
Autorzy :
Stewart, Adele
Davis, Gwynne L.Aff1, Aff2
Gresch, Paul J.Aff1, Aff3
Katamish, Rania M.
Peart, Rodeania
Rabil, Maximilian J.
Gowrishankar, RaajaramAff1, Aff2, Aff5
Carroll, F. Ivy
Hahn, Maureen K.Aff1, Aff3
Blakely, Randy D.Aff1, Aff3
Pokaż więcej
Źródło :
Neuropsychopharmacology: At the intersection of brain, behavior, and therapeutics. 44(5):994-1006
Czasopismo naukowe
Tytuł :
The rare DAT coding variant Val559 perturbs DA neuron function, changes behavior, and alters in vivo responses to psychostimulants
Autorzy :
Mergy Marc A.
Gowrishankar Raajaram
Gresch Paul J.
Gantz Stephanie C.
Williams John
Davis Gwynne L.
Wheeler C. Austin
Stanwood Gregg D.
Hahn Maureen K.
Blakely Randy D.
Pokaż więcej
Źródło :
Proceedings of the National Academy of Sciences of the United States of America. 111(44):15613-15613
Dostęp URL :
http://dx.doi.org/10.1073/pnas.1417294111
Czasopismo naukowe
Tytuł :
Serotonin transporter inhibition and 5-HT 2C receptor activation drive loss of cocaine-induced locomotor activation in DAT Val559 mice.
Autorzy :
Stewart A; Department of Biomedical Science, Florida Atlantic University, Jupiter, FL, USA.
Davis GL; Department of Biomedical Science, Florida Atlantic University, Jupiter, FL, USA.; Neuroscience Graduate Program, Vanderbilt University, Nashville, TN, USA.
Gresch PJ; Department of Biomedical Science, Florida Atlantic University, Jupiter, FL, USA.; Brain Institute, Florida Atlantic University, Jupiter, FL, USA.
Katamish RM; Department of Biomedical Science, Florida Atlantic University, Jupiter, FL, USA.
Peart R; Wilkes Honors College, Florida Atlantic University, Jupiter, FL, USA.
Rabil MJ; Department of Biomedical Science, Florida Atlantic University, Jupiter, FL, USA.
Gowrishankar R; Department of Biomedical Science, Florida Atlantic University, Jupiter, FL, USA.; Neuroscience Graduate Program, Vanderbilt University, Nashville, TN, USA.; International Scholars Program, Vanderbilt University, Nashville, TN, USA.
Carroll FI; Research Triangle Institute, Research Triangle Park, NC, USA.
Hahn MK; Department of Biomedical Science, Florida Atlantic University, Jupiter, FL, USA.; Brain Institute, Florida Atlantic University, Jupiter, FL, USA.
Blakely RD; Department of Biomedical Science, Florida Atlantic University, Jupiter, FL, USA. .; Brain Institute, Florida Atlantic University, Jupiter, FL, USA. .
Pokaż więcej
Źródło :
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology [Neuropsychopharmacology] 2019 Apr; Vol. 44 (5), pp. 994-1006. Date of Electronic Publication: 2018 Dec 21.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Cocaine/*pharmacology
Conditioning, Classical/*drug effects
Dopamine/*metabolism
Dopamine Plasma Membrane Transport Proteins/*drug effects
Dopamine Uptake Inhibitors/*pharmacology
Fluoxetine/*pharmacology
Locomotion/*drug effects
Methylphenidate/*pharmacology
Neostriatum/*drug effects
Neostriatum/*metabolism
Receptor, Serotonin, 5-HT2C/*drug effects
Serotonin Uptake Inhibitors/*pharmacology
Animals ; Behavior, Animal/drug effects ; Cocaine/analogs & derivatives ; Disease Models, Animal ; Dopamine Plasma Membrane Transport Proteins/genetics ; Mice ; Mice, 129 Strain ; Mice, Inbred C57BL ; Mice, Transgenic ; Serotonin Plasma Membrane Transport Proteins
Czasopismo naukowe
Tytuł :
Antipsychotic drug-like effects of the selective M4 muscarinic acetylcholine receptor positive allosteric modulator VU0152100.
Autorzy :
Byun NE; 1] Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt University Medical Center, Nashville, TN, USA [2] Department of Pharmacology, Vanderbilt University Medical Center, Nashville, TN, USA [3] Vanderbilt University Institute of Imaging Science, Vanderbilt University Medical Center, Nashville, TN, USA.
Grannan M; 1] Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt University Medical Center, Nashville, TN, USA [2] Department of Pharmacology, Vanderbilt University Medical Center, Nashville, TN, USA.
Bubser M; 1] Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt University Medical Center, Nashville, TN, USA [2] Department of Pharmacology, Vanderbilt University Medical Center, Nashville, TN, USA.
Barry RL; 1] Vanderbilt University Institute of Imaging Science, Vanderbilt University Medical Center, Nashville, TN, USA [2] Department of Radiology and Radiological Sciences, Vanderbilt University Medical Center, Nashville, TN, USA.
Thompson A; 1] Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt University Medical Center, Nashville, TN, USA [2] Department of Pharmacology, Vanderbilt University Medical Center, Nashville, TN, USA.
Rosanelli J; Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt University Medical Center, Nashville, TN, USA.
Gowrishankar R; 1] Neuroscience Graduate Program, Vanderbilt University, Nashville, TN, USA [2] Vanderbilt Brain Institute, Vanderbilt University, Nashville, TN, USA [3] Vanderbilt International Scholars Program, Vanderbilt University, Nashville, TN, USA.
Kelm ND; 1] Vanderbilt University Institute of Imaging Science, Vanderbilt University Medical Center, Nashville, TN, USA [2] Department of Biomedical Engineering, Vanderbilt University, Nashville, TN, USA.
Damon S; Vanderbilt University Institute of Imaging Science, Vanderbilt University Medical Center, Nashville, TN, USA.
Bridges TM; 1] Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt University Medical Center, Nashville, TN, USA [2] Department of Pharmacology, Vanderbilt University Medical Center, Nashville, TN, USA [3] Department of Chemistry, Vanderbilt University Medical Center, Nashville, TN, USA.
Melancon BJ; Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt University Medical Center, Nashville, TN, USA.
Tarr JC; Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt University Medical Center, Nashville, TN, USA.
Brogan JT; 1] Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt University Medical Center, Nashville, TN, USA [2] Department of Pharmacology, Vanderbilt University Medical Center, Nashville, TN, USA [3] Department of Chemistry, Vanderbilt University Medical Center, Nashville, TN, USA.
Avison MJ; 1] Department of Pharmacology, Vanderbilt University Medical Center, Nashville, TN, USA [2] Vanderbilt University Institute of Imaging Science, Vanderbilt University Medical Center, Nashville, TN, USA [3] Department of Radiology and Radiological Sciences, Vanderbilt University Medical Center, Nashville, TN, USA.
Deutch AY; 1] Department of Pharmacology, Vanderbilt University Medical Center, Nashville, TN, USA [2] Department of Psychiatry, Vanderbilt University Medical Center, Nashville, TN, USA.
Wess J; Molecular Signaling Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA.
Wood MR; 1] Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt University Medical Center, Nashville, TN, USA [2] Department of Chemistry, Vanderbilt University Medical Center, Nashville, TN, USA.
Lindsley CW; 1] Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt University Medical Center, Nashville, TN, USA [2] Department of Pharmacology, Vanderbilt University Medical Center, Nashville, TN, USA [3] Department of Chemistry, Vanderbilt University Medical Center, Nashville, TN, USA.
Gore JC; 1] Vanderbilt University Institute of Imaging Science, Vanderbilt University Medical Center, Nashville, TN, USA [2] Department of Radiology and Radiological Sciences, Vanderbilt University Medical Center, Nashville, TN, USA [3] Department of Biomedical Engineering, Vanderbilt University, Nashville, TN, USA.
Conn PJ; 1] Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt University Medical Center, Nashville, TN, USA [2] Department of Pharmacology, Vanderbilt University Medical Center, Nashville, TN, USA.
Jones CK; 1] Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt University Medical Center, Nashville, TN, USA [2] Department of Pharmacology, Vanderbilt University Medical Center, Nashville, TN, USA.
Pokaż więcej
Źródło :
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology [Neuropsychopharmacology] 2014 Jun; Vol. 39 (7), pp. 1578-93. Date of Electronic Publication: 2014 Jan 20.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Antipsychotic Agents/*pharmacology
Pyridines/*pharmacology
Receptor, Muscarinic M4/*agonists
Receptor, Muscarinic M4/*chemistry
Thiophenes/*pharmacology
Amphetamine/toxicity ; Animals ; Blood Pressure/drug effects ; Brain/drug effects ; Brain/pathology ; Cell Line, Transformed ; Central Nervous System Stimulants/toxicity ; Disease Models, Animal ; Dopamine Plasma Membrane Transport Proteins/genetics ; Dopamine Plasma Membrane Transport Proteins/metabolism ; Fear/drug effects ; Heart Rate/drug effects ; Humans ; Hyperkinesis/chemically induced ; Hyperkinesis/drug therapy ; Male ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; Motor Activity/drug effects ; Protein Binding/drug effects ; Rats ; Rats, Sprague-Dawley ; Receptor, Muscarinic M4/deficiency ; Receptor, Muscarinic M4/genetics ; Reflex, Startle/drug effects
Czasopismo naukowe
    Wyświetlanie 1-17 z 17

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies